US FDA approves Suprax 400 mg by Lupin

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

Mumbai: Lupin Pharmaceuticals, a subsidiary of India-based Lupin, has received approval for Suprax (Cefixime) Capsules 400 mg from the US Food and Drugs Administration (FDA). A statement re...Read more

Tiyanyin pharma all set for GMP inspection

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post insepction by China Food and Drug Administration (CFDA) expected to begi...Read more

Simcere, Zhuhai enter share transfer agreement

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharmaceutical (Boda). The company entered into a share transfer agreement ...Read more

New CoolPal Vertos Advance launched by Pelican BioThermal

Generics |  News | 0 Comment | 19 Jan, 2017

US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-controlled packaging solutions serving the life sciences industry has r...Read more

CEPI board meeting with a focus on identifying disease priorities and future strategy

Generics |  News | 0 Comment | 19 Dec, 2016

The Department of Biotechnology (DBT) will be partnering in the Coalition for Epidemic Preparedness and Innovations (CEPI) which is a new global alliance among governments, industries, acad...Read more